Search Results
Optimizing Lipid Risk Factors: Focus on Residual Risk, Dr. David Vorchheimer
Optimizing Lipid Risk Factors: Focus on Residual Risk
Beyond LDL: Assessing and Treating Residual ASCVD Risk | Marc-Andre Cornier, MD
Eckel Invited Lecture: Evaluating and Treating "Residual Risk" in ASCVD | Michael J. Blaha, MD, MPH
Residual cardiovascular risk. What is the role of icosapent ethyl?
Obstructive Sleep Apnea: Cardiology's Somnolent Risk Factor, Dr. David Vorchheimer
MSBI DOM Grand Rounds- Dr. Benjamin Hirsh
Grand Rounds 2021.02.24
TERCER ATENEO SOCIEDAD ARGENTINA DE LIPIDOS 2022
